本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

72.52
+0.85001.19%
成交量:63.90万
成交额:4,555.52万
市值:139.75亿
市盈率:-17.33
高:72.67
开:71.46
低:70.35
收:71.67
52周最高:75.10
52周最低:25.34
股本:1.93亿
流通股本:1.51亿
量比:0.50
换手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-4.1844
每股收益(LYR):-2.8793
净资产收益率:-1789.67%
总资产收益率:-43.47%
市净率:-7.23
市盈率(LYR):-25.19

数据加载中...

2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/29

重要事件披露

Form 8-K - Current report
2025/10/29

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report
2025/10/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities